Navigation Links
Death rate 70 percent lower at top-rated hospitals: HealthGrades annual hospital quality study
Date:10/13/2008

tentially been saved from 2005 to 2007.

  • Fifty-four percent (128,749) of the potentially preventable deaths were associated with just four diagnoses: Sepsis, heart failure, pneumonia and respiratory failure.

  • Variation in risk-adjusted mortality exists not only at the national level but also at the state and regional levels. The greatest quality differences between states occurred in hospital death rates for heart failure, pulmonary, stroke and cardiac surgery.

  • The region with the lowest overall risk-adjusted mortality rates was the East North Central region (IL, IN, MI, OH, and WI), while the East South Central region (AL, KY, MS, and TN) had the highest mortality rates.

  • The East North Central region (IL, IN, MI, OH, and WI), had the highest percentage of best-performing hospitals at 26 percent. Less than seven percent of hospitals within the New England region (CT, MA, ME, NH, RI, and VT) were top-performing hospitals.

    In the study's analysis of hospital death rates, the following 17 procedures and conditions were analyzed: bowel obstruction, chronic obstructive pulmonary disease, coronary bypass surgery, coronary interventional procedures (angioplasty/stent), diabetic acidosis and coma, gastrointestinal bleed, gastrointestinal surgeries and procedures, heart attack, heart failure, pancreatitis, pneumonia, pulmonary embolism, resection/replacement of the abdominal aorta, respiratory failure, sepsis, stroke, and valve replacement surgery. The full study, along with its methodology and state-by-state hospital-quality statistics, can be found at www.healthgrades.com.


    '/>"/>


  • Contact: Scott Shapiro
    sshapiro@healthgrades.com
    720-963-6584
    HealthGrades
    Source:Eurekalert

    Page: 1 2 3

    Related medicine news :

    1. Penn study finds pro-death proteins required to regulate healthy immune function
    2. Study, meta-analysis examine factors associated with death from heatstroke
    3. Antioxidants show no clear benefit against cardiovascular events, death in high-risk women
    4. Diabetes appears to increase risk of death for patients with acute coronary syndromes
    5. Diet high in meat, fat and refined grains linked to risk for colon cancer recurrence, death
    6. Longer ambulance journeys boost death risk for seriously ill patients
    7. Stopping Statins After Stroke Doubles Death Risk
    8. Oral Health a Matter of Life and Death for Seniors
    9. Pop stars more than twice as likely to die an early death
    10. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
    11. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    Other Medicine News:Health News:More women with early-stage breast cancer choosing double mastectomies 2Health News:HealthMapRx, Mirixa and the City of Asheville Announce New Partnership to Improve Health & Healthcare Savings of Beneficiaries With Chronic Diseases 2Health News:HealthMapRx, Mirixa and the City of Asheville Announce New Partnership to Improve Health & Healthcare Savings of Beneficiaries With Chronic Diseases 3Health News:Nuvilex, Inc. Announces Investor Conference Call and Open House 2Health News:Nuvilex, Inc. Announces Investor Conference Call and Open House 3Health News:Children's Home + Aid Faces Revenue Shortfall 2Health News:Lifeclinic Names New Executive Vice President as its Presence in Non-Retail Wellness Sector Grows 2Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 2Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 3Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 4Health News:Nuvilex, Inc.'s Marketing Partner, CK41 to Launch purEffect(TM) in May 5
    Breaking Medicine Technology:National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees' Choice New Product Awards 2PRA International Hosts an Infectious Diseases Audio Conference 2PRA International Hosts an Infectious Diseases Audio Conference 3The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 1The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 2The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 3The Westin Kierland Resort And Mayo Clinic Present 26quot 3BWell Beyond 26quot 3B Weekend 47697 4Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 1Network Merchants Inc 28NMI 29 Founders Donate 2450 000 to Schaumburgs Childrens Home 26 Aid 47692 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 1Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 2Photos 3A Philips Expands Home Healthcare Commitment With Portable Life Support Ventilator 3B Offers Ease of Use Portability and Versatility for Pati 47687 3
    Other Medicine Technology:Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 2Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 3Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 4Study Results Show Epratuzumab Provided Clinically Meaningful Reduced Disease Activity in Patients With Lupus 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 2CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 3CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 4CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 6CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 7CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 8CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 9CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 10